NICECACTUS/GLORY4GAMERS
26.2.2020 14:02:11 CET | Business Wire | Press release
Following the announcement of an initial funding round of €5 million at the end of 2019, Nicecactus has taken yet another step forward in its global development by acquiring Glory4Gamers. The strategic alliance of these two esports experts provides 1 million users with an all-in-one solution, combining knowledge in training and skill development as well as in organizing both online and offline tournaments. Players, partners and B2B customers alike can now benefit from the comprehensive range of services of these two stakeholders.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200226005081/en/
Since the end of January 2020, Nicecactus and Glory4Gamers have combined their expertise and solutions with the ambition to further expand internationally. The G4G teams have joined the Nicecactus family to form a 70-person team. They are reinforcing the already successful model of tournaments and competitions with prize money for players of all levels. In addition, the offline B2B event package, which enables brands (sponsors and publishers) to run promotional campaigns among qualified audiences, will be developed to become one of the pillars of the Nicecactus offer.
An all-in-one platform for aspiring champions
Amateur or semi-professional players, members of the Glory4Gamers and nicecactus.gg platforms, will now benefit from a complete solution empowering them with the professional training method they need to reach their full potential and realize their dream of becoming champions. It ranges from tailor-made training sessions (tutorials and drills), to performance assessment and analysis tools, as well as daily competitions with prizes and even networking with professional players in the sector (sponsors, teams) for the most talented of them.
All players are also eligible for the Nicecactus Grassroots Esports Fund, a $1 million grant program, through which they can cover travel and accommodation expenses to participate in bootcamps at professional training locations or tournaments they have qualified for.
“The decision to acquire Glory4Gamers fits perfectly with our strategy to develop and strengthen our unique offer, which encompasses virtually all aspects of esports, from amateurs to semi-professional players, as well as companies wishing to address this highly qualified target audience,” explains Mike Hessabi, Founder & President of Nicecactus.
"The esports market is growing at breakneck speed, and we want more than ever to be at the heart of this ecosystem. Nicecactus approaches esports with an innovative vision and great ambitions. The combination of Glory4Gamers and Nicecactus felt obvious to us, as we have a very aligned vision and complementary skills," adds Cyril Chomette, CEO and Founder of Glory4Gamers.
About Nicecactus:
First ever all-encompassing esports platform, Nicecactus took root in the sun-bathed French Riviera. Its goal is to foster aspiring esports players who wish to unleash their gaming potential and master their game. Nicecactus provides them with a professional training method as well as all the tools they need to fulfill their dream of becoming champions. Players from all over the world are encouraged to give the best out of themselves, through a continued training program, a fined-tuned stats tracking system and the opportunity to compete in tournaments and make some cash out of their passion in a challenging and fun way. Its first-of-its-kind Nicecactus Grassroots Esports Fund rewards the best players for their talent and dedication by connecting them to the professional world. www.nicecactus.gg
About Glory4Gamers:
Founded in 2012, Glory4Gamers is a pioneer in amateur esports. Now the leading organizer of esports tournaments in France and 3rd in Europe, the platform holds more than 2,000 tournaments per month. Through its unique real-time refereeing component, Glory4Gamers promises its users a unique esports experience, in a fun and fair play environment, and with a human support close at hand.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200226005081/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom